Condition

Hepatitis C (3)

Cirrhosis (1)

Cryoglobulinemia (1)

Genotype 1 Hepatitis C Virus (1)

HIV (1)

Overall Status

Completed (3)

Unknown status (1)

Phase

phase 4 (2)

phase 2/phase 3 (1)

Sponsor

Gilead Sciences (1)

Icahn School of Medicine at Mount Sinai (1)

University of California, San Francisco (1)

University of Nebraska (1)

Collaborator

Columbia University (1)

Georgetown University (1)

Gilead Sciences (1)

Icahn School of Medicine at Mount Sinai (1)

Johns Hopkins University (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

National Institutes of Health Clinical Center (CC) (1)

University of Maryland, College Park (1)

University of Pennsylvania (1)

Intervention

harvoni (4)

epclusa (1)

Study Documents

Intervention Type

drug (4)

Funder Type

Other (3)

Industry (1)

Study Type

Interventional (3)

Observational (1)

harvoni

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hepatitis C, Cryoglobulinemia Trial in New York (Harvoni, Epclusa)

Completed

Has Results

Hepatitis C
Cryoglobulinemia

Harvoni
Epclusa

New York, New York

Icahn School of Medicine at Mount Sinai

Nov 23, 2020

Genotype 1 Hepatitis C Virus Trial in Omaha (harvoni)

Unknown status

Genotype 1 Hepatitis C Virus

harvoni

Omaha, Nebraska

University of Nebraska

Dec 9, 2019

HIV, Hepatitis C, Cirrhosis Trial in United States (Harvoni)

Completed

Has Results

HIV
+2 more

Harvoni

San Francisco, California
+7 more

Jan 12, 2021

Harvoni® in Japanese Chronic Genotype 1 Hepatitis C Virus

Completed

Hepatitis C

Harvoni

Ageo-shi, Japan
+124 more

Feb 4, 2019